Skip to content
healthcare.dev

TicoVac

NDC 0069-0297, Tick-Borne Encephalitis Vaccine, injection, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0297
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125740
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0297 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)1.2 ug/.25mL
Package NDCNDC-11Package
0069-0297-02000690297021 SYRINGE in 1 CARTON (0069-0297-02) / .25 mL in 1 SYRINGE (0069-0297-01)
0069-0297-100006902971010 SYRINGE in 1 CARTON (0069-0297-10) / .25 mL in 1 SYRINGE (0069-0297-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0069-0297 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0297 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0297. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.